Abacavir rechallenge has to be avoided in case of hypersensitivity reaction

被引：68
作者：
Escaut, L
Liotier, JY
Albengres, E
Cheminot, N
Vittecoq, D
机构：
[1] Hop Paul Brousse, Unite Malad Infect, F-94804 Villejuif, France
[2] Ctr Hosp Intercommunal, Ctr Reg Pharmacovigilance, F-94010 Creteil, France
来源：
AIDS | 1999年 / 13卷 / 11期
关键词：
D O I：
10.1097/00002030-199907300-00026
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1419 / 1420
页数：2
相关论文
共 3 条
[1]   Lack of pharmacodynamic interaction between trimetazidine and cyclosporin A in human lymphoproliferative and mouse delayed hypersensitivity response models [J].
Albengres, E ;
Tillement, JP ;
dAthis, P ;
Salducci, D ;
ChauvetMonges, AM ;
Crevat, A .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1996, 10 (03) :264-268
[2]   Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults [J].
Saag, MS ;
Sonnerborg, A ;
Torres, RA ;
Lancaster, D ;
Gazzard, BG ;
Schooley, RT ;
Romero, C ;
Kelleher, D ;
Spreen, W ;
LaFon, S .
AIDS, 1998, 12 (16) :F203-F209
[3]  
TSUTSUI H, 1992, J IMMUNOL, V149, P706
1